GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Abeona Therapeutics ABEO · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.42

-1.22%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Abeona Therapeutics — daily ABEO Delayed
Market value
$131.1m
Last close × shares
Volume
4.7m
Shares, 20 Nov 2026
Price to earnings
3.2

About Abeona Therapeutics

From its filings with the US Securities and Exchange Commission

SEC filings

Abeona Therapeutics is based in Cleveland, Ohio and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ABEO. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $5.8m and net income of $71.2m. At that date it held total assets of $219.6m and shareholders' equity of $159.2m. By business, License [Member] brought in 58.4% of revenue, followed by Product [Member] at 41.6%.

Read the filing on SEC.gov ↗

More about Abeona Therapeutics →

How it makes its money

Revenue, year to 31 Dec 2025

  • License [Member] $3.4m · 58.4%
  • Product [Member] $2.4m · 41.6%

Latest on Abeona Therapeutics

Our reporting

Next results

16 Mar 2027

Due on 16 Mar 2027. Analysts expect earnings of -0.25 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Abeona Therapeutics's ticker?

Abeona Therapeutics trades as ABEO on its US listing, under ISIN US00289Y2063.

What was Abeona Therapeutics's last closing price?

2.42 on 20 Nov 2026. The figure is in USD and is never converted.

When does Abeona Therapeutics next report results?

Results are expected on 11 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.